BioMarin Pharmaceutical EBITDA Margin 2010-2024 | BMRN

BioMarin Pharmaceutical ebitda margin for the quarter ending September 30, 2024 was 12.98%.

  • BioMarin Pharmaceutical average ebitda margin for 2023 was 9.25%, a 6.09% increase from 2022.
  • BioMarin Pharmaceutical average ebitda margin for 2022 was 9.85%, a 624.26% decline from 2021.
  • BioMarin Pharmaceutical average ebitda margin for 2021 was 1.36%, a 79.88% increase from 2020.

Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.

BioMarin Pharmaceutical EBITDA Margin 2010-2024 | BMRN

  • BioMarin Pharmaceutical average ebitda margin for 2023 was 9.25%, a 6.09% increase from 2022.
  • BioMarin Pharmaceutical average ebitda margin for 2022 was 9.85%, a 624.26% decline from 2021.
  • BioMarin Pharmaceutical average ebitda margin for 2021 was 1.36%, a 79.88% increase from 2020.

Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.